Investing Profile

Hakan Goker

InvestorVC
Managing Director at M Ventures
m-ventures.com/enAmsterdam, Netherlands
Photo of Hakan Goker, Managing Director at MDC Ventures (formerly KBS Ventures)
Your Intro Paths to Hakan Goker

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Hakan is a member of
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
UCL Network
104 CONNECTIONS

Find Hakan Goker on

cb
Current Investing Position
MDC Ventures (formerly KBS Ventures) Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
25

Hakan Goker is on these Sector & Stage Rankings

Hakan Goker's Investments On Record (13)

CompanyStageDateRound SizeTotal Raised
TRIMTECH Therapeutics
SeedJun 2026$14M
SeedMar 2025$31M
$45M
Co-investors: Jeffrey Moore (MP Healthcare Venture Management), Laurence Barker (SV Health Investors' Dementia Discovery Fund (DDF)), Michael Anstey (Cambridge Innovation Capital)
Storm Therapeutics
Series CApr 2026$56M
Series BDec 2022$30M
Series AMay 2019$18M
Series AJun 2016$16M
$130M
Co-investors: Sakae Asanuma (Hotmail), Bruno Montanari (Seroba Life Sciences), Robert Tansley (Cambridge Innovation Capital)
Artios Pharma
Series DNov 2025$120M
Series CJul 2021$150M
Series ASep 2016$33M
$380M
Co-investors: Raphael Wisniewski (Andera Partners), Barbara Dalton (Pfizer Venture Investments), René Kuijten (EQT Life Sciences), Florian Müllershausen (Novartis Venture Fund), Nikola Trbovic (Pfizer Venture Investments), Jake Simson (RA Capital Management)
Actithera
Series AJul 2025$76M
$76M
Co-investors: Therese Liechtenstein (MDC Ventures (formerly KBS Ventures)), Noga Yerushalmi (MDC Ventures (formerly KBS Ventures))
ReproNovo
Series AMay 2025$65M
$65M
Asceneuron
Series CJul 2024$100M
Series ASep 2015$31M
$130M
Co-investors: Henrijette Richter (Sofinnova Partners), Philip Scheltens (EQT Life Sciences)
iOnctura
Series BJun 2024$86M
Series AJul 2020$6M
Series AJan 2020$17M
SeedJun 2017
$110M
Co-investors: Keno Gutierrez (BGV (BioGeneration Ventures)), Thijs Cohen Tervaert (INKEF Capital), Roel Bulthuis (Syncona Limited), Fiona MacLaughlin (Johnson & Johnson Innovation)
Nouscom
Series CNov 2023$73M
$140M
Co-investors: Scott Rocklage (5am Ventures), Guido Magni (Versant Ventures), Joachim Rothe (EQT Life Sciences), Genghis Lloyd-Harris (Abingworth), Sofia Ioannidou (Andera Partners)

Hakan Goker's Experience

Committee Chairman HotmailPresent
Board member HotmailPresent
Managing Director HotmailPresent
Advisory Board Member BioPartner UKPresent
Senior Investment Director M VenturesPresent
Board Director SynaffixPresent
Board Director and previous acting CBO &Observer Asceneuron SAPresent
Board Director Progyny, Inc.Present
Board Director Raze Therapeutics, Inc.Present
Venture Capital Platform Council Member Invest EuropePresent
Board Director HotmailPresent
Board Member STORM Therapeutics LimitedPresent
Board Member ArtiosPresent
Chairman Of The Board iOncturaPresent
Board Member Ribometrix Inc.Present
Executive Investment Director M VenturesPresent
Vice President, Head of Healthcare Investments M VenturesPresent
Board Member (ex- founding chairman) iOncturaPresent
Managing Director M VenturesPresent
Chairman ActitheraPresent
Board Member NouscomPresent
Board Member ReproNovoPresent
Board Member TRIMTECH Therapeutics LimitedPresent
Board Observer NRG TherapeuticsPresent
Partner AescapPresent

Hakan Goker's Education

The Institute of Cancer Research BSc Hons Human Genetics
UCL BSc Hons Human Genetics
University of London PhD Molecular Genetics

Founders who looked at Hakan Goker's profile also looked at these Scouts & Angels

Photo of Christopher Priebe, Angel

Photo of Justin Waldron, Angel

Photo of Brad Holden, Managing Partner

Photo of Morgan Beller, General Partner